Home » Newsletters » BioWorld

BioWorld

May 2, 2000

View Archived Issues

Magainin, Genentech Enter $66M Deal For Asthma Antibody

New Photofrin Marketing Partner Frees QLT To Focus On Visudyne

288 Canadian Schizophrenics Donate Blood To Track Disease Proneness To Chromosome 1

Arena Files To Raise $100M In Initial Offering

Schering-Plough, Enzon Release Positive Phase III PEG-Intron Data

Ares-Serono's Rebif High Dose Therapy Shows Benefit In Early MS

Other News To Note